drugset / Trial / NCT00387036

Exercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036)

NCT00387036

Phase 2 Terminated 12 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverDouble-blindTreatment

Summary

To test the effect of the research study drug, inhaled fluticasone on lung function in exercising patients with Chronic Obstructive Pulmonary Disease (COPD).

Timeline

Start
2006-12
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone Other / unclassified 500 ug Inhaled